Here are some of the key consequences of the recent US climate withdrawals and what they mean for countries like Switzerland.

Brussels has granted a humanitarian exemption to Jacques Baud, a former Swiss colonel who has been sanctioned by the EU for promoting conspiracy narratives and false claims about the war in Ukraine.

Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.

We are glad that Isomorphic is helping advance the field and are able to match the level of performance we demonstrated at the ARDD conference in Copenhagen last August. In August, Deep Origin ...

Demis Hassabis is the co-founder and CEO of Google DeepMind, an AI research laboratory responsible for development of the Gemini large language model and AlphaFold, a system that revolutionized the ...

Google and Microsoft's new WebMCP standard lets websites expose callable tools to AI agents through the browser — replacing ...

AI is flipping software development from execution to oversight. Here's how intent, validation and governance are replacing ...

The unveiling of the Isomorphic Labs Drug Design Engine (IsoDDE) represents a fundamental shift from merely predicting the ...

Isomorphic Labs has raised $600m in its first external funding round as it pushes forward with artificial intelligence (AI)-driven drug discovery. Thrive Capital led the financing round, with ...

Discover how researchers are overcoming the limitations of the undruggable target in drug discovery using novel approaches ...

AI is reshaping software development, shifting work from coding to orchestration, governance, and skills evolution while teams adapt, retrain, and build trust in AI systems.

London Tech Week 2026 Agenda Goes Live As New Wave Of Global Founders And Enterprise Leaders Announced. EINPresswire/ -- London Tech Week today announces that the full agenda for 2026 is now live, ...